🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was an open-label, multicenter study designed to evaluate the safety a...
Status
Terminated
Location
John B. Amos Cancer Center - C /ID# 202055
Start Date
2018-10-18
Trial ID
NCT03567616
Treatments Being Tested
This study will evaluate the safety, antitumor activity and preliminary pha...
Status
Completed
Location
Mayo Clinic
Start Date
2016-09
Trial ID
NCT02900716
Treatments Being Tested
This study will assess the efficacy, safety and tolerability of pomalidomid...
Status
Completed
Location
Stanford University Cancer Center
Start Date
2017-09-18
Trial ID
NCT03257631
Treatments Being Tested
There is a high unmet medical need for an anti-myeloma therapy for RRMM pat...
Status
Completed
Location
LKH Feldkirch, Intern E, Hämatologie
Start Date
2015-02-20
Trial ID
NCT02555839
Treatments Being Tested
The main goal of this phase II study is to evaluate the overall response ra...
Status
Recruiting
Location
Massachusetts General Hospital
Start Date
2024-05-31
Trial ID
NCT05922501
Treatments Being Tested
This is a randomized, multicenter, Phase 3, open-label study evaluating sub...
Status
Active Not Recruiting
Location
Mohtaseb Cancer Center and Blood Disorders Site Number : 8400028
Start Date
2022-06-23
Trial ID
NCT05405166
The purpose of this study is to compare the efficacy of pomalidomide and lo...
Status
Terminated
Location
Multiple Locations
Start Date
2015-10-19
Trial ID
NCT02576977
Treatments Being Tested
The study is designed as a multicenter, non-randomized, Phase II trial with...
Status
Completed
Location
Klinikum rechts der Isar der TU München / III. Med. Klinik und Poliklinik
Start Date
2018-09-20
Trial ID
NCT03731832
Treatments Being Tested
The purpose of this study is to determine the efficacy and toxicity profile...
Status
Completed
Location
CHRU-Hôpital Sud Amiens
Start Date
2012-01
Trial ID
NCT01745640
Treatments Being Tested
The purpose of this study is to determine if adding Elotuzumab to Pomalidom...
Status
Completed
Location
Winship Cancer Institute
Start Date
2016-03-18
Trial ID
NCT02654132
Treatments Being Tested